Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) saw a significant increase in short interest during the month of June. As of June 30th, there was short interest totaling 34,933 shares, an increase of 81.8% from the June 15th total of 19,219 shares. Based on an average trading volume of 35,762 shares, the days-to-cover ratio is presently 1.0 days. Currently, 1.6% of the shares of the stock are sold short.
Invesco Nasdaq Biotechnology ETF Stock Up 0.1%
Shares of NASDAQ:IBBQ opened at $32.62 on Friday. The company has a market capitalization of $73.72 million, a P/E ratio of 17.03 and a beta of 0.60. Invesco Nasdaq Biotechnology ETF has a 52-week low of $21.87 and a 52-week high of $34.22. The stock’s fifty day simple moving average is $30.70 and its 200-day simple moving average is $29.71.
Invesco Nasdaq Biotechnology ETF Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, June 26th. Investors of record on Monday, June 22nd were paid a $0.0342 dividend. The ex-dividend date of this dividend was Monday, June 22nd. This represents a $0.14 annualized dividend and a yield of 0.4%.
Institutional Investors Weigh In On Invesco Nasdaq Biotechnology ETF
Invesco Nasdaq Biotechnology ETF Company Profile
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Featured Stories
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
